ACTA2, also known as α-smooth muscle actin (α-SMA), is a key characteristic of CAFs, whose high stromal expression was associated with enhanced angiogenesis, tumor growth, lymph node metastasis, frequency of cancer stem cells and worse clinical outcome [28–32]. The gene discussed is ACTA2; the disease is metastatic malignant neoplasm in the lymph nodes.